Skip to NavigationSkip to content

News

Novartis' groundbreaking cancer drug has been recommended for first-line treatment of chronic myeloid leukaemia (CML).
New Health Secretary Dr John Reid has committed the NHS to continued reform despite a growing chorus of disapproval over the central role of...
Several major pharma companies have shown their long-term commitment to the UK by investing millions of pounds in new and expanded facilities.
AstraZeneca has settled the case relating to fraudulent sales of its prostate cancer drug Zoladex, and will pay a total of $354.9 million.
The Department of Health is to open itself up to the same 'radical transformation' it is overseeing in the NHS by inviting management consultants to...
New bodies intended to allow doctors and nurses to cut through red tape and re-build services around the patient have added to NHS bureaucracy and...
Doctors across the UK have overwhelmingly voted in favour of the new GP contract, ending months of uncertainty about the reform of general practice.
The future of the US healthcare system and how patients pay for their medicines will be decided in the coming weeks as a long-running battle for...
Pfizer has criticised the US approval of an over-the-counter formulation of AstraZeneca's heartburn drug Prilosec, saying it will only serve to...
The fate of the new GP contract is hanging in the balance after doctors claim to have found a massive miscalculation that would see them worse off...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches